Biotech Stocks To Watch And Pharma Industry NewsTrack the latest trends and leading stocks in the biotech and pharmaceutical industries. The post Biotech Stocks To Watch And Pharma Industry News appeared first on Investor's Business Daily.

[Collection]

One minute Dow Jones industrial average component Merck (MRK) might be doing battle with fellow drugmaker Bristol-Myers Squibb (BMY) over drugs that can ward off cancer.

X

The next, biotech giants like Amgen (AMGN) and Sanofi (SNY) are tussling in court over the fate of cholesterol-busting drugs. Meanwhile, a company like Gilead Sciences (GILD) might be raked over the coals in Congress for charging $1,000 a day to treat hepatitis.

It's a brave — and contentious — new world for pharmaceutical and biotechnology companies. It's a realm where science is trying to develop landmark medicines that cure cancer, hepatitis and other life-threatening illnesses.

All the while it does a delicate dance with Wall Street and regulators — balancing public health issues with the demands of shareholders. Investors will find it tricky to navigate the sector, as companies can rise and fall at the drop of a hat.

Bookmark this page to stay on top of the latest news in the biopharma sector.

Biotech And Pharma News

Mylan Jumps After Reiterating 2018 Outlook Despite Quarterly Sales DipMylan stock surged late Monday after the generic pharma reiterated its 2018 guidance despite missing third-quarter sales expectations. In after-hours trading on the stock market today, Mylan stock jumped 5.8%, near 33.20.... Read More

Breakout Watch: Big Pharma Stock Abbott Laboratories Nears Buy ZoneAbbott Laboratories didn't join Cigna, Express Scripts, UnitedHealth and nine other medical sector stocks on latest list of new buys by the best mutual funds. But the Big Pharma and medical devices company... Read More

Why Bausch Health Could See Last Year Of Decline In 2018: AnalystBausch Health Companies stock popped higher Monday after an analyst upgraded it on "an inflection of new product drivers" expected to push growth in 2020. On the stock market today, Bausch Health... Read More

This Small Biotech Could Chip Away At Sales Of Key Amgen DrugCoherus Biosciences will chip away at nearly $1 billion in quarterly revenue for Amgen, an analyst said Monday after the smaller biotech gained approval for its Neulasta biosimilar. Neulasta, a bone marrow-stimulating... Read More

IBD 50 Stocks To Watch: This Stock Rallied Despite A Miss On Earnings And RevenueSmall-cap biotech Innoviva has built its business around pharmaceutical partnerships. Its flagship alliance with GlaxoSmithKline is its chief partnership. Innoviva receives royalties from Glaxo for drugs that treat asthma and chronic obstructive... Read More

IBD Rating Upgrades: AnaptysBio Flashes Improved Price StrengthOn Monday, AnaptysBio got a positive adjustment to its Relative Strength (RS) Rating, from 67 to 75. As you try to find the best stocks to buy and watch, be sure to... Read More

Arena Pharmaceuticals Meets 80-Plus Relative Strength Rating BenchmarkWhen looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Arena Pharmaceuticals, which had its Relative Strength... Read More

View More Biotech And Pharma Stock News

Get instant access to more trading ideas, exclusive stock lists and IBD proprietary ratings for only $5.

RELATED:

Best Stocks To Buy And Watch

The post Biotech Stocks To Watch And Pharma Industry News appeared first on Investor's Business Daily.

http://feedproxy.google.com/~r/BusinessRss/~3/K5zsmUmuL5I/